• Pharma
  • May 20, 2025
  • 276 views
Lupin to boost complex generics in US, EU; eyes chronic growth in India

Lupin, which plans to develop the specialty business, is eyeing higher revenue share from its complex generics portfolios in the US and Europe. Moreover, with a pipeline of over 200…

  • Pharma
  • February 24, 2025
  • 442 views
Lupin receives US FDA Establishment Inspection Report for Somerset facility

Lupin has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility in Somerset, New Jersey.…